BHC
Price
$5.24
Change
-$0.43 (-7.58%)
Updated
Apr 4, 11:06 AM (EDT)
Capitalization
3.86B
26 days until earnings call
DVAX
Price
$12.85
Change
-$0.02 (-0.16%)
Updated
Apr 3 closing price
Capitalization
1.62B
27 days until earnings call
Ad is loading...

BHC vs DVAX

Header iconBHC vs DVAX Comparison
Open Charts BHC vs DVAXBanner chart's image
Bausch Health Companies
Price$5.24
Change-$0.43 (-7.58%)
Volume$5.98K
Capitalization3.86B
Dynavax Technologies
Price$12.85
Change-$0.02 (-0.16%)
Volume$2.53M
Capitalization1.62B
BHC vs DVAX Comparison Chart
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. DVAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Buy and DVAX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BHC: $5.67 vs. DVAX: $12.85)
Brand notoriety: BHC: Notable vs. DVAX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 89% vs. DVAX: 111%
Market capitalization -- BHC: $3.86B vs. DVAX: $1.62B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. DVAX’s [@Pharmaceuticals: Other] market capitalization is $1.62B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green whileDVAX’s FA Score has 0 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • DVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, DVAX is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 4 TA indicator(s) are bullish while DVAX’s TA Score has 5 bullish TA indicator(s).

  • BHC’s TA Score: 4 bullish, 7 bearish.
  • DVAX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than BHC.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а -16.00% price change this week, while DVAX (@Pharmaceuticals: Other) price change was -6.34% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.00%. For the same industry, the average monthly price growth was -2.21%, and the average quarterly price growth was -10.30%.

Reported Earning Dates

BHC is expected to report earnings on Apr 30, 2025.

DVAX is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than DVAX($1.62B). DVAX has higher P/E ratio than BHC: DVAX (31.63) vs BHC (13.39). DVAX YTD gains are higher at: 0.626 vs. BHC (-29.653). BHC has higher annual earnings (EBITDA): 2.2B vs. DVAX (9.67M). BHC has more cash in the bank: 947M vs. DVAX (742M). DVAX has less debt than BHC: DVAX (257M) vs BHC (22.4B). BHC has higher revenues than DVAX: BHC (8.76B) vs DVAX (232M).
BHCDVAXBHC / DVAX
Capitalization3.86B1.62B238%
EBITDA2.2B9.67M22,781%
Gain YTD-29.6530.626-4,733%
P/E Ratio13.3931.6342%
Revenue8.76B232M3,775%
Total Cash947M742M128%
Total Debt22.4B257M8,716%
FUNDAMENTALS RATINGS
BHC vs DVAX: Fundamental Ratings
BHC
DVAX
OUTLOOK RATING
1..100
6985
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10047
SMR RATING
1..100
10084
PRICE GROWTH RATING
1..100
8652
P/E GROWTH RATING
1..100
9796
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for DVAX (73) in the Biotechnology industry. This means that BHC’s stock grew somewhat faster than DVAX’s over the last 12 months.

DVAX's Profit vs Risk Rating (47) in the Biotechnology industry is somewhat better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew somewhat faster than BHC’s over the last 12 months.

DVAX's SMR Rating (84) in the Biotechnology industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to BHC’s over the last 12 months.

DVAX's Price Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for BHC (86) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew somewhat faster than BHC’s over the last 12 months.

DVAX's P/E Growth Rating (96) in the Biotechnology industry is in the same range as BHC (97) in the Pharmaceuticals Other industry. This means that DVAX’s stock grew similarly to BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCDVAX
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VFL10.350.10
+0.93%
abrdn National Municipal Income Fund
SAT24.580.08
+0.33%
Saratoga Investment Corp
EMCR29.11-0.59
-1.99%
Xtrackers EM CarbReduc&ClimtImprvs ETF
QSPT25.78-1.02
-3.80%
FT Vest Nasdaq-100® Buffer ETF Sep
BSVO18.20-1.52
-7.71%
EA Bridgeway Omni Small-Cap Value ETF

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-0.16%
ACET - DVAX
39%
Loosely correlated
-7.32%
SNDL - DVAX
35%
Loosely correlated
-1.39%
SUPN - DVAX
29%
Poorly correlated
-1.01%
ETON - DVAX
27%
Poorly correlated
-5.73%
ALKS - DVAX
25%
Poorly correlated
-3.03%
More